Literature DB >> 20083946

COX2 inhibitors for acquired brain injuries: is the time ripe?

Kenneth I Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20083946      PMCID： PMC3313841          DOI： 10.1097/CCM.0b013e3181bc80b9

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  21 in total

1.  COX-2 inhibitors--a lesson in unexpected problems.

Authors:  Jeffrey M Drazen
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

2.  COX-2 inhibitors--lessons in drug safety.

Authors:  Bruce M Psaty; Curt D Furberg
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

4.  Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Authors:  Nancy A Nussmeier; Andrew A Whelton; Mark T Brown; Richard M Langford; Andreas Hoeft; Joel L Parlow; Steven W Boyce; Kenneth M Verburg
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

5.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

6.  Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.

Authors:  Nancy Fathali; Robert P Ostrowski; Tim Lekic; Vikram Jadhav; Wenni Tong; Jiping Tang; John H Zhang
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

7.  NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2.

Authors:  M A Blom; M G van Twillert; S C de Vries; F Engels; C E Finch; R Veerhuis; P Eikelenboom
Journal:  Brain Res       Date:  1997-11-28       Impact factor: 3.252

8.  Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia.

Authors:  Dong Liu; Liejun Wu; Richard Breyer; Mark P Mattson; Katrin Andreasson
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

9.  A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue.

Authors:  Hongfei Yue; Susan A Jansen; Kenneth I Strauss; Michael R Borenstein; Mary F Barbe; Luella J Rossi; Elise Murphy
Journal:  J Pharm Biomed Anal       Date:  2006-11-27       Impact factor: 3.935

Review 10.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217
View more
  3 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

Review 2.  Using anesthetics and analgesics in experimental traumatic brain injury.

Authors:  Rachel K Rowe; Jordan L Harrison; Theresa C Thomas; James R Pauly; P David Adelson; Jonathan Lifshitz
Journal:  Lab Anim (NY)       Date:  2013-08       Impact factor: 12.625

3.  Neuronal and nonneuronal COX-2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge.

Authors:  Ying An; Natalya Belevych; Yufen Wang; Hao Zhang; Harvey Herschman; Qun Chen; Ning Quan
Journal:  J Neurosci Res       Date:  2013-12-24       Impact factor: 4.164
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.